Pure Global
NCT06374108

Resistance Training and Corticospinal Excitability in Multiple Sclerosis

Effects of Supervised Progressive Resistance Training on Central Nervous System Functioning (Corticospinal Excitability) and Walking Capacity in Persons With Multiple Sclerosis
University of Aarhus·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Multiple Sclerosis
Drug/Device/Intervention
Progressive resistance training
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of Aarhus
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
May 31, 2026
Enrollment
54 participants
Primary outcome

MEP/Mmax ratio

Summary

The goal of the present study is to investigate effects of progressive resistance training on
 central nervous system functioning (corticospinal excitability (CSE)) and walking capacity in
 persons with multiple sclerosis (pwMS). A total of 54 pwMS will be enrolled and randomized
 into 1 of 3 groups: high dose resistant training (RT), low dose RT, and waitlist control.

ICD-10 classifications
Multiple sclerosisProgressive systemic sclerosisSystemic sclerosisSystemic sclerosis, unspecifiedDiffuse sclerosis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06374108
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06374108 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Aarhus and is currently Not yet recruiting. The study focuses on Multiple Sclerosis. Target enrollment is 54 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.